Levocar (Carbidopa, Levodopa)

Levodopa is a precursor that crosses the blood‑brain barrier and is converted to dopamine within the central nervous system. Carbidopa inhibits the enzyme dopa decarboxylase in peripheral tissues, preventing premature conversion of levodopa to dopamine outside the brain. This dual action maximizes the amount of levodopa reaching the brain while reducing peripheral side effects.

The specific dose of Levocar is individualized and determined by the prescribing clinician based on disease severity, patient age, renal and hepatic function, and response to therapy. Physicians typically start with a low dose and titrate upward to achieve optimal symptom control while minimizing adverse effects.

Safety data for carbidopa/levodopa during pregnancy and lactation are limited. The drug should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the Levocar product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the enquiry, the team will request trade or institutional credentials, then respond with pricing, availability, shipping details (including cold‑chain if required) and the necessary import documentation.

Levocar provides direct dopamine replacement, whereas dopamine agonists (e.g., ropinirole, pramipexole) stimulate dopamine receptors without increasing dopamine levels. Levodopa generally offers more robust motor improvement but may be associated with dyskinesia over long‑term use. Choice of therapy depends on disease stage, patient age, side‑effect profile, and clinician judgment.

Levocar tablets should be stored at ambient temperature, preferably below 25 °C, in their original container to protect from moisture and light. Keep the medication out of reach of children and avoid storing in bathrooms or other humid environments.

Levocar is taken orally, usually with a small amount of food to reduce nausea, but large protein‑rich meals may interfere with absorption. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse events include dyskinesia (involuntary movements), neuropsychiatric effects such as hallucinations or psychosis, severe orthostatic hypotension, and rare but life‑threatening reactions like neuroleptic malignant syndrome or anaphylaxis. Patients should be monitored regularly for these complications, especially after dose changes.

Levocar is contraindicated in individuals with known hypersensitivity to carbidopa, levodopa, or any excipients. It should also be avoided in patients currently taking non‑selective MAO inhibitors, those with narrow‑angle glaucoma, or patients with a history of severe cardiovascular instability unless closely supervised.